 |
|
Relation of Plasma Lipids to Alzheimer Disease and Vascular Dementia
Christiane Reitz, MD;
Ming-Xin Tang, PhD;
Jose Luchsinger, MD;
Richard Mayeux, MD
Arch Neurol. 2004;61:705-714.
Background The relation between plasma lipid levels and Alzheimer disease (AD) and vascular dementia (VaD), and the impact of drugs to lower lipid levels remains unclear.
Objective To investigate the relation between plasma lipid levels and the risk of AD and VaD and the impact of drugs to lower lipid levels on this relationship.
Design and Setting Cross-sectional and prospective community-based cohort studies.
Participants Random sample of 4316 Medicare recipients, 65 years and older, residing in northern Manhattan, NY.
Main Outcome Measures Vascular dementia and AD according to standard criteria.
Results Elevated levels of non–high-density lipoprotein (HDL-C) and low-density lipoprotein cholesterol (LDL-C) and decreased levels of HDL-C were weak risk factors for VaD in either cross-sectional or prospective analyses. Higher levels of total cholesterol were associated with a decreased risk of incident AD after adjustment for demographics, apolipoprotein E genotype, and cardiovascular risk factors. Treatment with drugs to lower lipid levels did not change the disease risk of either disorder.
Conclusions We found a weak relation between non–HDL-C, LDL-C, and HDL-C levels and the risk of VaD. Lipid levels and the use of agents to lower them do not seem to be associated with the risk of AD.
From the Gertrude H. Sergievsky Center (Drs Reitz, Tang, Luchsinger, and Mayeux), the Taub Institute for Research on Alzheimer's Disease and the Aging Brain (Drs Luchsinger and Mayeux), the Departments of Medicine (Dr Luchsinger), Neurology (Dr Mayeux), and Psychiatry (Dr Mayeux), and the Departments of Biostatistics (Dr Tang) and Epidemiology (Dr Mayeux) in the Mailman School of Public Health, Columbia University College of Physicians and Surgeons, New York, NY.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis
Anstey et al.
AJGP 2008;16:343-354.
ABSTRACT
| FULL TEXT
Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders
Akerblom et al.
Age Ageing 2008;37:207-213.
ABSTRACT
| FULL TEXT
Characterization of the Lipid Profile in Dementia and Depression in the Elderly
Dimopoulos et al.
J Geriatr Psychiatry Neurol 2007;20:138-144.
ABSTRACT
The Relation between Apolipoprotein A-I and Dementia: The Honolulu-Asia Aging Study
Saczynski et al.
Am J Epidemiol 2007;165:985-992.
ABSTRACT
| FULL TEXT
Invited Commentary: Lipoproteins and Dementia--Is It the Apolipoprotein A-I?
Scarmeas
Am J Epidemiol 2007;165:993-997.
ABSTRACT
| FULL TEXT
Serum cholesterol changes after midlife and late-life cognition: Twenty-one-year follow-up study
Solomon et al.
Neurology 2007;68:751-756.
ABSTRACT
| FULL TEXT
Twenty-six-Year Change in Total Cholesterol Levels and Incident Dementia: The Honolulu-Asia Aging Study
Stewart et al.
Arch Neurol 2007;64:103-107.
ABSTRACT
| FULL TEXT
Education and rates of cognitive decline in incident Alzheimer's disease.
Scarmeas et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:308-316.
ABSTRACT
| FULL TEXT
Serum cholesterol and risk of Alzheimer disease: A community-based cohort study
Li et al.
Neurology 2005;65:1045-1050.
ABSTRACT
| FULL TEXT
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger et al.
Neurology 2005;65:545-551.
ABSTRACT
| FULL TEXT
High total cholesterol levels in late life associated with a reduced risk of dementia
Mielke et al.
Neurology 2005;64:1689-1695.
ABSTRACT
| FULL TEXT
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The Three-City Study
Dufouil et al.
Neurology 2005;64:1531-1538.
ABSTRACT
| FULL TEXT
|
